ストックスクリーナーアプリを入手
1.11
3.74%
0.04
アフターアワーズ：
1.13
0.02
+1.80%
Humacyte Inc (HUMA) 最新ニュース
Can Humacyte Inc. Equity Warrant stock beat market expectations this quarter2025 Retail Activity & Fast Gaining Stock Strategy Reports - Улправда
Is Humacyte Inc. Equity Warrant stock affected by interest rate hikesCEO Change & Reliable Breakout Forecasts - Улправда
Humacyte announces credit facility of $77.5M with Avenue Capital - MSN
Humacyte enters sales agreement with TD Securities - MSN
Humacyte's US$28m Market Cap Fall Books Insider Losses - simplywall.st
Humacyte Enters Sales Agreement with TD Securities - TipRanks
Humacyte may offer and sell shares of common stock of up to $60 million from time to time through TD Cowen, acting as agent - marketscreener.com
Humacyte (NASDAQ: HUMA) details $60M at the market stock offering - Stock Titan
[424B5] Humacyte, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Investment Review: Is Humacyte Inc Equity Warrant stock a contrarian buyJuly 2025 Short Interest & Expert Curated Trade Setups - moha.gov.vn
Humacyte secures up to $77.5 million credit facility with Avenue Capital - Investing.com Nigeria
Humacyte secures $77.5 million loan facility - MSN
Humacyte announces credit facility of up to $77.5 million with Avenue Capital - marketscreener.com
Humacyte Signs $77.5 Million Credit Facility - marketscreener.com
Humacyte Secures $77.5 Million Credit Facility with Avenue Venture Opportunities Fund to Support Growth and Development Initiatives - Quiver Quantitative
Humacyte, Inc. Announces Credit Facility of Up to $77.5 Million with Avenue Capital - marketscreener.com
Total debt per share of Humacyte, Inc. Warrant 2021-27.08.26 on Humacyte – NASDAQ:HUMAW - TradingView — Track All Markets
Humacyte Secures $77.5 Million Loan Facility - TipRanks
[8-K] Humacyte, Inc. Reports Material Event | HUMA SEC FilingForm 8-K - Stock Titan
Humacyte terminates revenue interest purchase agreement - marketscreener.com
Humacyte Terminates Revenue Interest Agreement - TipRanks
Wall Street Zen Upgrades Humacyte (NASDAQ:HUMA) to "Hold" - MarketBeat
Is Humacyte Inc a good long term investmentStraddle and Strangle Trades & Explosive Capital Growth Plans - earlytimes.in
Humacyte (HUMA): Benchmark remains bullish on stock - MSN
Humacyte Stock (HUMA) Opinions on FDA Approval for Symvess Product - Quiver Quantitative
Humacyte (HUMA): Benchmark Remains Bullish on Stock - Finviz
11 Best Micro-Cap Stocks to Invest in According to Analysts - Insider Monkey
Humacyte prices 28.4M shares at $2.11 in registered direct offering - MSN
Market Moves: Can Humacyte Inc stock weather global recessionPortfolio Risk Report & Reliable Intraday Trade Plans - moha.gov.vn
Bond Watch: Will Humacyte Inc Equity Warrant stock pay special dividendsJuly 2025 Volume & Low Volatility Stock Recommendations - BỘ NỘI VỤ
Book value per share of Humacyte, Inc. Warrant 2021-27.08.26 on Humacyte – NASDAQ:HUMAW - TradingView
Wall Street analysts see Humacyte, Inc. (HUMA) as a buy: Should you invest? - MSN
Wall Street Analysts See Humacyte, Inc. (HUMA) as a Buy: Should You Invest? - Finviz
How Humacyte Inc. Equity Warrant stock reacts to global recession fearsBuy Signal & High Accuracy Buy Signal Tips - Newser
Can Humacyte Inc. stock continue upward trendPortfolio Growth Summary & Momentum Based Trading Signals - Newser
Humacyte, Inc. (NASDAQ:HUMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates - MSN
Humacyte, Inc.'s (NASDAQ:HUMA) largest shareholders are retail investors with 57% ownership, institutions own 26% - Yahoo Finance
Will Humacyte Inc. stock maintain growth storyForecast Cut & High Accuracy Trade Alerts - Newser
Can Humacyte Inc. stock maintain growth trajectoryMarket Volume Summary & Fast Moving Stock Trade Plans - BỘ NỘI VỤ
Humacyte (HUMA) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Humacyte stock rating reiterated at Buy by H.C. Wainwright - Investing.com Canada
What drives Humacyte Inc stock priceGap Up/Gap Down Analysis & Collaborate and Win Together - earlytimes.in
Humacyte, Inc. (NASDAQ:HUMA) Q4 2024 Earnings Call Transcript - MSN
Humacyte (HUMA) Q3 2025 Earnings Call Transcript - The Globe and Mail
Humacyte Ends Sale Agreement with Jefferies LLC - MSN
HumacyteOn Nov 21, co delivered notice to Jefferies terminating open market sale agreement entered on Sept 1, 2022 - MarketScreener
Aug Closing: What catalysts could drive Humacyte Inc. stock higherJuly 2025 Analyst Calls & Consistent Profit Alerts - BỘ NỘI VỤ
Aug Wrap: Can Humacyte Inc. stock maintain growth trajectory2025 Retail Activity & Growth Oriented Trading Recommendations - moha.gov.vn
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish - MSN
Humacyte’s Major Breakthroughs Impress Investors: Market Reactions - StocksToTrade
Stock Traders Purchase Large Volume of Humacyte Put Options (NASDAQ:HUMA) - MarketBeat
Humacyte Inc. (HUMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
0.31%
0.33%
大文字化:
|
ボリューム (24 時間):